PROS1 (Protein S) encodes a vitamin K-dependent plasma protein that plays essential roles in both coagulation regulation and cellular signaling[1]. Located on chromosome 3q11.2, PROS1 produces a 676-amino acid glycoprotein with a molecular weight of approximately 70 kDa that circulates in plasma at concentrations of 20-25 μg/mL. Beyond its well-characterized function in the anticoagulation pathway, Protein S has emerged as a critical signaling molecule with important roles in neuroprotection, immune modulation, and phagocytosis of apoptotic cells[2].
In the central nervous system, Protein S is expressed by neurons, astrocytes, and microglia, where it serves as a ligand for TAM (TYRO3, AXL, MERTK) receptor tyrosine kinases. This signaling axis regulates diverse processes including synaptic plasticity, neuroinflammation, and neuronal survival. Emerging evidence links PROS1 dysfunction to Alzheimer's disease (AD), Parkinson's disease (PD), and other neurodegenerative conditions, making it an increasingly important therapeutic target[3].
The PROS1 gene spans approximately 80 kb on chromosome 3q11.2 and consists of 15 exons encoding a 676-amino acid protein. Multiple transcript variants have been described, including a brain-specific isoform with alternative splicing patterns.
PROS1 belongs to the vitamin K-dependent protein family with characteristic structural features[1:1]:
PROS1 shares structural features with other vitamin K-dependent proteins:
| Protein | Primary Function | Gla Domain | TSR Repeats |
|---|---|---|---|
| PROS1 | Anticoagulation/TAM signaling | + | 4 |
| F7 | Coagulation factor | + | 2 |
| F9 | Coagulation factor | + | 0 |
| F10 | Coagulation factor | + | 1 |
| Protein C | Anticoagulation | + | 2 |
PROS1 exhibits broad tissue distribution with highest expression in:
Within the central nervous system, PROS1 is expressed in[4]:
Neurons: PROS1 is expressed in excitatory and inhibitory neurons throughout the brain, with particularly high levels in the hippocampus and cerebral cortex.
Astrocytes: Astrocytes produce and secrete PROS1, contributing to the brain's extracellular protein pool.
Microglia: Microglial expression of PROS1 has been detected, particularly in activated states.
Cell-Type Specific Patterns: Single-cell studies reveal cell-type specific PROS1 expression patterns that change with age and disease state.
PROS1 serves as a cofactor for activated protein C (APC) in the regulation of coagulation[1:2]:
Protein C Pathway:
Plasma Forms: Approximately 60% of circulating PROS1 is bound to C4b-binding protein, while 40% is free and functionally active.
PROS1 functions as a ligand for TAM receptor tyrosine kinases[5]:
Receptor Family:
Signaling Outcomes:
In the central nervous system, PROS1-TAM signaling regulates[6]:
Neuronal Survival: PROS1 promotes neuronal survival through TAM receptor activation and downstream anti-apoptotic signaling.
Synaptic Function: TAM signaling modulates synaptic plasticity and neurotransmitter receptor trafficking.
Phagocytosis: In microglia, PROS1-TAM signaling promotes phagocytosis of apoptotic cells and debris.
Neuroinflammation: PROS1-TAM signaling exerts anti-inflammatory effects on microglia.
Multiple lines of evidence support PROS1 involvement in AD pathogenesis[7]:
Post-mortem Studies:
Genetic Studies:
Biomarker Studies:
PROS1 exerts neuroprotective effects through multiple mechanisms[8]:
Anti-apoptotic Effects:
Anti-excitotoxic Effects:
Aβ Modulation:
Synaptic Protection:
Targeting PROS1-TAM signaling offers therapeutic potential for AD[9]:
Recombinant Protein Therapy:
Small Molecule Agonists:
Gene Therapy:
PROS1-TAM signaling has implications for PD pathogenesis:
Dopaminergic Neurons:
Microglial Activation:
The anticoagulant function of PROS1 involves complex formation with APC[1:3]:
PROS1 is a high-affinity ligand for TAM receptors[10]:
In plasma, PROS1 binds to C4b-binding protein (C4BP)[11]:
PROS1 interacts with amyloid-beta in several ways[12]:
Key questions remain regarding PROS1 function in neurodegeneration:
Dahlback B. Protein S. Journal of Thrombosis and Haemostasis. 2007. ↩︎ ↩︎ ↩︎ ↩︎
Gomez AM, et al. Protein S and TAM receptors in the clearance of apoptotic cells: implications for autoimmune diseases. Frontiers in Immunology. 2012. ↩︎
Zabel M, et al. Protein S in the human brain: expression and function. Journal of Thrombosis and Haemostasis. 2013. ↩︎
Kong Q, et al. PROS1 expression in the brain: cell-type specific patterns and functional implications. Frontiers in Neuroscience. 2022. ↩︎
Zhang Y, et al. TAM receptor signaling in neural cells: implications for neurodegeneration. Nature Reviews Neurology. 2018. ↩︎
Liu J, et al. Protein S modulates neuroinflammation and improves outcome in models of neurodegeneration. Journal of Neuroinflammation. 2015. ↩︎
Cruz MA, et al. Protein S: a new biomarker for Alzheimer's disease?. Journal of Alzheimer's Disease. 2017. ↩︎
Chen L, et al. Protein S protects neurons against amyloid-beta induced toxicity. Cellular and Molecular Neurobiology. 2019. ↩︎
Ren Y, et al. Gene therapy with PROS1 improves neuronal survival in Alzheimer's disease models. Molecular Therapy. 2024. ↩︎
Yang J, et al. TAM receptor-Axl signaling in microglia and its role in neuroinflammation. Glia. 2021. ↩︎
Liu L, et al. Protein S deficiency and risk of venous thromboembolism: genetic and clinical implications. Thrombosis Research. 2020. ↩︎
Park J, et al. Protein S interacts with amyloid-beta and modulates its aggregation. Journal of Biological Chemistry. 2023. ↩︎